These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6152485)

  • 21. Opioids modulate post-ischemic progression in a rat model of stroke.
    Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
    Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.
    Jamensky NT; Gianoulakis C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1455-64. PubMed ID: 9394118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
    Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
    Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.
    Zhang S; Tong Y; Tian M; Dehaven RN; Cortesburgos L; Mansson E; Simonin F; Kieffer B; Yu L
    J Pharmacol Exp Ther; 1998 Jul; 286(1):136-41. PubMed ID: 9655852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime.
    Király KP; Riba P; D'Addario C; Di Benedetto M; Landuzzi D; Candeletti S; Romualdi P; Furst S
    Brain Res Bull; 2006 Jul; 70(3):233-9. PubMed ID: 16861108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical aspects of drug intoxication: opioids and opiates.
    Goldfrank L; Bresnitz E; Weisman R
    Heart Lung; 1983 Mar; 12(2):114-22. PubMed ID: 6298150
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of new compounds for opioid activity annual report (1993).
    Woods JH; France CP; Medzihradsky F; Smith CB; Winger GD
    NIDA Res Monogr; 1994; 140():196-247. PubMed ID: 8722466
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morphinics receptors and endorphines (author's transl)].
    de Luna Infante MJ; Pérez Carvajal A
    Rev Esp Anestesiol Reanim; 1981 Sep; 28(5):293-300. PubMed ID: 6276945
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence of involvement of the nNOS and the kappa-opioid receptor in the same intracellular network of the rat periaqueductal gray that controls morphine tolerance and dependence.
    Herráez-Baranda LA; Carretero J; González-Sarmiento R; Laorden ML; Milanés MV; Rodríguez RE
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):166-73. PubMed ID: 15950775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiological investigations of opiate tolerance and dependence in the central nervous system.
    Henriksen SJ
    NIDA Res Monogr; 1984; 54():239-59. PubMed ID: 6152487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular mechanisms of opioid tolerance and the clinical approach to the opioid tolerant patient in the post-operative period.
    de Leon-Casasola OA
    Best Pract Res Clin Anaesthesiol; 2002 Dec; 16(4):521-5. PubMed ID: 12516889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Opiate and opioid tolerance: toxico-kinetic and toxico-dynamic aspects].
    Golovko AI; Golovko SI; Leont'eva LV; Rudnev VV; Konoplin DA; Romanenko OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(8):82-92. PubMed ID: 14564788
    [No Abstract]   [Full Text] [Related]  

  • 36. Metal ion interactions with opiates.
    Chapman DB; Way EL
    Annu Rev Pharmacol Toxicol; 1980; 20():553-79. PubMed ID: 6104470
    [No Abstract]   [Full Text] [Related]  

  • 37. Annual report: biological testing program of the Committee on Problems of Drug Dependence, Inc. (1979).
    Jacobson AE
    NIDA Res Monogr; 1979; 27():351-5. PubMed ID: 121357
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of opioid bimodality to tolerance/dependence formation. From transmitter release to second messenger formation.
    Gintzler AR
    Adv Exp Med Biol; 1995; 373():73-83. PubMed ID: 7668163
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute and chronic tolerance: relevance for clinical practice.
    Rosow C
    NIDA Res Monogr; 1987; 76():29-34. PubMed ID: 3125462
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of opioid drugs on human plasma cholinesterase.
    Gero A
    Life Sci; 1979 Jul; 25(3):201-8. PubMed ID: 225628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.